Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rescue Therapies for Steroid-refractory Acute Severe Ulcerative Colitis: A Review
Javier P. Gisbert, María José García, María Chaparro
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 6, pp. 972-994
Closed Access | Times Cited: 35

Showing 1-25 of 35 citing articles:

Acute severe ulcerative colitis management: unanswered questions and latest insights
Pauline Rivière, C Li Wai Suen, María Chaparro, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 3, pp. 251-262
Open Access | Times Cited: 19
Upadacitinib Salvage Therapy for Infliximab-Experienced Patients with Acute Severe Ulcerative Colitis
Robert Gilmore, Wei Lian Tan, R Fernandes, et al.
Journal of Crohn s and Colitis (2023) Vol. 17, Iss. 12, pp. 2033-2036
Open Access | Times Cited: 36
Effectiveness and safety of a third‐line rescue treatment for acute severe ulcerative colitis refractory to infliximab or ciclosporin (REASUC study)
María José García, Sabino Riestra, Aurélien Amiot, et al.
Alimentary Pharmacology & Therapeutics (2024) Vol. 59, Iss. 10, pp. 1248-1259
Closed Access | Times Cited: 13
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
Matthew C. Choy, C Li Wai Suen, Danny Con, et al.
˜The œLancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 11, pp. 981-996
Closed Access | Times Cited: 13
The JAK-STAT Pathway as a Therapeutic Strategy in Cancer Patients with Immune Checkpoint Inhibitor-Induced Colitis: A Narrative Review
Antonietta Gerarda Gravina, Raffaele Pellegrino, Alfonso Esposito, et al.
Cancers (2024) Vol. 16, Iss. 3, pp. 611-611
Open Access | Times Cited: 11
Modern practical management of acute severe colitis
Alaa Mohamed Anwar AbdelMeguid, Emma Whitehead, Shaji Sebastian
Indian Journal of Gastroenterology (2024) Vol. 43, Iss. 1, pp. 78-92
Closed Access | Times Cited: 5
Effectiveness of tacrolimus therapy in refractory ulcerative colitis compared to infliximab with propensity score matching
Takeo Yoshihara, Takahiro Amano, Shinichiro Shinzaki, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Intensified and Accelerated Rescue Infliximab Therapy for Acute Severe Ulcerative Colitis in Pregnancy: A Case Report
Saiumaeswar Yogakanthi, Timothy S. Phan, Emma Flanagan, et al.
JGH Open (2025) Vol. 9, Iss. 1
Open Access
Janus kinase inhibitors in the management of acute severe ulcerative colitis: a comprehensive review
Javier P. Gisbert, María Chaparro
Journal of Crohn s and Colitis (2025) Vol. 19, Iss. 2
Closed Access
Small Molecules in the Treatment of Acute Severe Ulcerative Colitis: A Review of Current Evidence
Raffaele Pellegrino, Giuseppe Imperio, Ilaria De Costanzo, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 3, pp. 308-308
Open Access
What to do when traditional rescue therapies fail in acute severe ulcerative colitis
C Li Wai Suen, Matthew C. Choy, Peter De Cruz
Intestinal Research (2024) Vol. 22, Iss. 4, pp. 397-413
Open Access | Times Cited: 3
Predicting Outcome after Acute Severe Ulcerative Colitis: A Contemporary Review and Areas for Future Research
Sudheer K. Vuyyuru, Olga Maria Nardone, Vipul Jairath
Journal of Clinical Medicine (2024) Vol. 13, Iss. 15, pp. 4509-4509
Open Access | Times Cited: 3
In-hospital management of inflammatory bowel disease
Jeffrey Berinstein, Daniel Aintabi, Peter Higgins
Current Opinion in Gastroenterology (2023) Vol. 39, Iss. 4, pp. 274-286
Closed Access | Times Cited: 8
Intestinal ultrasound scan predicts corticosteroid failure and colectomy risk in patients with ulcerative colitis
Baisi Yuan, Pengfei Huang, Miaofang Yang, et al.
European Journal of Gastroenterology & Hepatology (2024) Vol. 36, Iss. 7, pp. 884-889
Closed Access | Times Cited: 2
Current Management of Acute Severe Ulcerative Colitis: New Insights on the Surgical Approaches
Sara Lauricella, Francesco Brucchi, Federica Cavalcoli, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 6, pp. 580-580
Open Access | Times Cited: 2
Real-world long-term effectiveness of ustekinumab in ulcerative colitis: results from a spanish open-label cohort
Marisa Iborra, R Ferreiro-Iglesias, Martín-Arranz Maria Dolores, et al.
Scandinavian Journal of Gastroenterology (2023) Vol. 59, Iss. 3, pp. 260-268
Closed Access | Times Cited: 7
Management of acute severe ulcerative colitis—an update for generalist and specialist clinicians
Anish John Kuriakose Kuzhiyanjal, Jimmy K. Limdi
British Medical Bulletin (2024) Vol. 151, Iss. 1, pp. 3-15
Closed Access | Times Cited: 2
Effectiveness and safety of upadacitinib in acute severe ulcerative colitis patients from single Chinese IBD Center: a monocentric study
Jiaqi Zhang, Ruixia Li, Ling Chen, et al.
Clinical and Experimental Medicine (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 2
Top-down infliximab plus azathioprine versus azathioprine alone in patients with acute severe ulcerative colitis responsive to intravenous steroids: a parallel, open-label randomised controlled trial, the ACTIVE trial
Aurélien Amiot, Philippe Marteau, Antoine Meyer, et al.
Gut (2024), pp. gutjnl-333281
Closed Access | Times Cited: 2
Utility of Tofacitinib in Steroid-Refractory Acute Severe Ulcerative Colitis
Mukesh Kumar Ranjan, Pradeep Neupane, Bigyan Maharjan
Cureus (2024)
Open Access | Times Cited: 1
Common Mistakes in Managing Patients with Inflammatory Bowel Disease
Javier P. Gisbert, María Chaparro
(2024)
Open Access | Times Cited: 1
Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management
Antonio M.� Caballero-Mateos, Guillermo A. Cañadas‐De la Fuente
World Journal of Gastroenterology (2024) Vol. 30, Iss. 35, pp. 3942-3953
Closed Access | Times Cited: 1
The impact of colectomy and restorative procedure on pouch function after ileo-pouch-anal anastomosis in ulcerative colitis. The icon fun study on behalf of the Italian Society of Colon and Rectal Surgery (SICCR) Inflammatory Bowel Diseases committee
Michela Mineccia, Alessandro Ferrero, Matteo Rottoli, et al.
Digestive and Liver Disease (2024)
Closed Access | Times Cited: 1
Future of Acute Severe Ulcerative Colitis—A Narrative Review
Leshni Pillay, Janakan Selvarajah, B. L. Andrew, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 24, pp. 7723-7723
Open Access | Times Cited: 1
Small Molecules, Big Results: How JAK Inhibitors Have Transformed the Treatment of Patients with IBD
Kush Fansiwala, Jenny Sauk
Digestive Diseases and Sciences (2024)
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top